565 related articles for article (PubMed ID: 31995655)
21. mTORC1 and mTORC2 play different roles in regulating cardiomyocyte differentiation from embryonic stem cells.
Zheng B; Wang J; Tang L; Shi J; Zhu D
Int J Dev Biol; 2017; 61(1-2):65-72. PubMed ID: 28287249
[TBL] [Abstract][Full Text] [Related]
22. PTH(1‑34) activates the migration and adhesion of BMSCs through the rictor/mTORC2 pathway.
Lv Z; Muheremu A; Bai X; Zou X; Lin T; Chen B
Int J Mol Med; 2020 Dec; 46(6):2089-2101. PubMed ID: 33125102
[TBL] [Abstract][Full Text] [Related]
23. Rapamycin and mTORC2 inhibition synergistically reduce contraction-stimulated muscle protein synthesis.
Ogasawara R; Knudsen JR; Li J; Ato S; Jensen TE
J Physiol; 2020 Dec; 598(23):5453-5466. PubMed ID: 32893874
[TBL] [Abstract][Full Text] [Related]
24. Targeting mTORC1/2 with OSI-027 inhibits proliferation and migration of keloid keratinocytes.
Chen J; Liu K; Liu Y; Wang X; Zhang Z
Exp Dermatol; 2019 Mar; 28(3):270-275. PubMed ID: 30650200
[TBL] [Abstract][Full Text] [Related]
25. Genetic inactivation of mTORC1 or mTORC2 in neurons reveals distinct functions in glutamatergic synaptic transmission.
McCabe MP; Cullen ER; Barrows CM; Shore AN; Tooke KI; Laprade KA; Stafford JM; Weston MC
Elife; 2020 Mar; 9():. PubMed ID: 32125271
[TBL] [Abstract][Full Text] [Related]
26. Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition.
Ruicci KM; Plantinga P; Pinto N; Khan MI; Stecho W; Dhaliwal SS; Yoo J; Fung K; MacNeil D; Mymryk JS; Barrett JW; Howlett CJ; Nichols AC
Mol Oncol; 2019 Oct; 13(10):2160-2177. PubMed ID: 31393061
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of mTORC2/RICTOR Impairs Melanoma Hepatic Metastasis.
Schmidt KM; Dietrich P; Hackl C; Guenzle J; Bronsert P; Wagner C; Fichtner-Feigl S; Schlitt HJ; Geissler EK; Hellerbrand C; Lang SA
Neoplasia; 2018 Dec; 20(12):1198-1208. PubMed ID: 30404068
[TBL] [Abstract][Full Text] [Related]
28. Rapamycin inhibits cytoskeleton reorganization and cell motility by suppressing RhoA expression and activity.
Liu L; Luo Y; Chen L; Shen T; Xu B; Chen W; Zhou H; Han X; Huang S
J Biol Chem; 2010 Dec; 285(49):38362-73. PubMed ID: 20937815
[TBL] [Abstract][Full Text] [Related]
29. mTOR Directs Breast Morphogenesis through the PKC-alpha-Rac1 Signaling Axis.
Morrison MM; Young CD; Wang S; Sobolik T; Sanchez VM; Hicks DJ; Cook RS; Brantley-Sieders DM
PLoS Genet; 2015 Jul; 11(7):e1005291. PubMed ID: 26132202
[TBL] [Abstract][Full Text] [Related]
30. Remarkable inhibition of mTOR signaling by the combination of rapamycin and 1,4-phenylenebis(methylene)selenocyanate in human prostate cancer cells.
Facompre ND; Sinha I; El-Bayoumy K; Pinto JT; Sinha R
Int J Cancer; 2012 Nov; 131(9):2134-42. PubMed ID: 22307455
[TBL] [Abstract][Full Text] [Related]
31. Selective disruption of mTORC1 and mTORC2 in VTA astrocytes induces depression and anxiety-like behaviors in mice.
Zheng Z; Zhou H; Yang L; Zhang L; Guo M
Behav Brain Res; 2024 Apr; 463():114888. PubMed ID: 38307148
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of PI3K-Akt-mTOR signaling in glioblastoma by mTORC1/2 inhibitors.
Fan QW; Weiss WA
Methods Mol Biol; 2012; 821():349-59. PubMed ID: 22125077
[TBL] [Abstract][Full Text] [Related]
33. Role of Raptor Gene Variants in Hypertension: Influence on Blood Pressure Independent of Salt Intake in White Population.
Aljaibeji H; Heydarpour M; Stanton AM; Williams JS; Pojoga LH; Romero JR; Williams GH
Hypertension; 2024 May; 81(5):1167-1177. PubMed ID: 38497230
[TBL] [Abstract][Full Text] [Related]
34. Mechanistic Target of Rapamycin Signaling Activation Antagonizes Autophagy To Facilitate Zika Virus Replication.
Sahoo BR; Pattnaik A; Annamalai AS; Franco R; Pattnaik AK
J Virol; 2020 Oct; 94(22):. PubMed ID: 32878890
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of 6-phosphofructo-2-kinase (PFKFB3) by hyperactivated mammalian target of rapamycin complex 1 is critical for tumor growth in tuberous sclerosis complex.
Wang Y; Tang S; Wu Y; Wan X; Zhou M; Li H; Zha X
IUBMB Life; 2020 May; 72(5):965-977. PubMed ID: 31958214
[TBL] [Abstract][Full Text] [Related]
36. GSK3 is required for rapalogs to induce degradation of some oncogenic proteins and to suppress cancer cell growth.
Koo J; Wang X; Owonikoko TK; Ramalingam SS; Khuri FR; Sun SY
Oncotarget; 2015 Apr; 6(11):8974-87. PubMed ID: 25797247
[TBL] [Abstract][Full Text] [Related]
37. Differential dependence of hypoxia-inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2.
Toschi A; Lee E; Gadir N; Ohh M; Foster DA
J Biol Chem; 2008 Dec; 283(50):34495-9. PubMed ID: 18945681
[TBL] [Abstract][Full Text] [Related]
38. Functional Role of mTORC2 versus Integrin-Linked Kinase in Mediating Ser473-Akt Phosphorylation in PTEN-Negative Prostate and Breast Cancer Cell Lines.
Lee SL; Chou CC; Chuang HC; Hsu EC; Chiu PC; Kulp SK; Byrd JC; Chen CS
PLoS One; 2013; 8(6):e67149. PubMed ID: 23840605
[TBL] [Abstract][Full Text] [Related]
39. Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin.
Toschi A; Lee E; Xu L; Garcia A; Gadir N; Foster DA
Mol Cell Biol; 2009 Mar; 29(6):1411-20. PubMed ID: 19114562
[TBL] [Abstract][Full Text] [Related]
40. mTOR hyperactivity and
Sztankovics D; Moldvai D; Petővári G; Dankó T; Szalai F; Miyaura R; Varga V; Nagy N; Papp G; Pápay J; Krencz I; Sebestyén A
Pathol Oncol Res; 2024; 30():1611643. PubMed ID: 38515456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
